يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Aitor Almanza"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: National University of Ireland [Galway] (NUI Galway), Cancer Research UK Cambridge Institute [Cambridge, Royaume-Uni] (CRUK), University of Cambridge [UK] (CAM), Oncogenesis, Stress, Signaling (OSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CRLCC Eugène Marquis (CRLCC), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Biomedical Research Foundation of the Academy of Athens (BRFAA), NUI Galway, Science Foundation Ireland, Irish Government's Program for Research in Third Level Institutions, Cycle 5, European Regional Development Fund, Precision Oncology Ireland - Science Foundation Ireland (SFI) Strategic Partnership Program [18/SPP/3522], EU H2020 MSCA [RISE-734749, ITN-675448], SFI Industry Fellowship [18/IF/6247], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: Nature Communications
    Nature Communications, 2022, 13 (1), pp.2493. ⟨10.1038/s41467-022-30159-0⟩
    Nature Communications, Nature Publishing Group, 2022, 13 (1), pp.2493. ⟨10.1038/s41467-022-30159-0⟩

    وصف الملف: Electronic

  4. 4
  5. 5
  6. 6

    المساهمون: National University of Ireland [Galway] (NUI Galway), Fosun Orinove PharmaTech Inc.[Newbury Park, CA], Chemistry, Oncogenesis, Stress and Signaling (COSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CRLCC Eugène Marquis (CRLCC), Fosun Orinove PharmaTech Inc.[Jiangsu], University of Applied Sciences [Rheinbach], NUI Galway, Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007-2013, Institut National du Cancer (INCa) [PLBIO 2017-148], Irish Cancer Society Scholarship [CRS11CLE], Thomas Crawford Hayes Funds of NUIG, Irish Research Council Employment Based Programme Scholarship Scheme [BPPG/2014/57], Irish Research Council Fellowship [GOIPD/2014/53], Breast Cancer Campaign grant [2010NovPR13, 2015MaySP550], Health Research Board [HRA-POR-2014-643], Belgium Grant [IAP 7/32], Science Foundation Ireland (SFI) grant - European Regional Development Fund [13/RC/2073], SFI Starting Investigator Grant [15/SIRG/3528], EU H2020 MSCA [ITN-675448, RISE-734749], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Jonchère, Laurent

    المصدر: Nature Communications
    Nature Communications, 2018, 9 (1), pp.3267. ⟨10.1038/s41467-018-05763-8⟩
    Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
    Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.3267. ⟨10.1038/s41467-018-05763-8⟩
    Nature Communications volume 9, Article number: 3267 (2018)

    وصف الملف: application/pdf

  7. 7

    المساهمون: Breast Cancer Now, Health Research Board, Belgium Grant, Science Foundation Ireland, Irish Research Council, Clinical Research Development Ireland, Enterprise Ireland, College of Science, NUI Galway, Thomas Crawford Hayes Fund, NUI Galway

    المصدر: Biochemical and Biophysical Research Communications

    وصف الملف: application/pdf